Results 201 to 210 of about 37,898 (281)

Real-World Evaluation of the Dosage Patterns and Safety of Angiotensin Receptor-Neprilysin Inhibitor Therapy in Indian Patients With Heart Failure With Reduced Ejection Fraction: The ADD-ARNI Study Protocol. [PDF]

Cureus
Mittal S, Mehta A, Sharma K, Jayagopal PB, Pande A, Sugumaran A, Sawant S, Mohanasundaram S.   +7 more
europepmc   +1 more source

Prognostic differences between persistent HFrEF and HFrecEF following acute myocardial infarction. [PDF]

Front Cardiovasc Med
Jang JY, Lee JM, Shin Y, Kim YL, Yu G, Bae JS, Cho YH, Kwak CH, Kang MG, Kim KH, Park JR, Hwang JY, Jeong YH, Ahn JH.   +13 more
europepmc   +1 more source

60 A comparison of HFrEF vs HFpEF’s clinical workload and cost in the first year following hospitalisation and enrollment in a disease management program

Journal of the American College of Cardiology, 2016
J. McEvoy, J. McEvoy, Yan Chen, Andreea M. Rawlings, R. Hoogeveen, C. Ballantyne, R. Blumenthal, Joseph Coresh, E. Selvin   +8 more
semanticscholar   +1 more source

Breaking new ground in heart failure management: novel therapies and future frontiers. [PDF]

Front Cardiovasc Med
Khalid A, Rodriguez P, Tasouli-Drakou V, Ahmed AB, Thatcher S, Dugal JK, Singh A.   +6 more
europepmc   +1 more source

Improving the Management of Patients with Heart Failure with Reduced Ejection Fraction in Clinical Practice: The Case for Angiotensin Receptor-Neprilysin Inhibitor. [PDF]

Card Fail Rev
Iacoviello M, Maria Sarullo F, Bilato C, Correale M, Di Gesaro G, Driussi M, Passantino A, Villani A, Di Lenarda A.   +8 more
europepmc   +1 more source

Guideline-directed medical strategies for the co-management of heart failure and metabolic dysfunction-associated steatotic liver disease. [PDF]

Commun Med (Lond)
Gries JJ, Chen B, Bansal MB, Rodriguez M, Alqahtani SA, Brennan PN, Lang CC, Tang WHW, Lazarus JV, Krittanawong C.   +9 more
europepmc   +1 more source

Pharmacological Therapy of HFrEF in 2025: Navigating New Advances and Old Unmet Needs in An Eternal Balance Between Progress and Perplexities. [PDF]

Card Fail Rev
Mapelli M, Rubbo FM, Costantino S, Amelotti N, Agostoni P.   +4 more
europepmc   +1 more source

Heart failure with reduced ejection fraction polypill implementation strategy in Sri Lanka: design and protocol of a pilot type I hybrid randomised clinical trial. [PDF]

BMJ Open
Agarwal A, de Silva A, Agarwal M, Ajanthan S, Dahanayaka A, Dhurjati R, Fernando C, Galappatthy G, Goss CW, Hively A, Jayagopal PB, Mohanan PP, Patel A, Prabhakaran D, Rahuman M, Rodgers A, Roberts K, Salwa H, Huffman MD, Salam A.   +19 more
europepmc   +1 more source

Current state of medication treatment practice for heart failure with reduced ejection fraction among cardiologists in Japan: a survey on the relationship between satisfaction levels and adherence to guideline-directed medical therapy. [PDF]

BMC Cardiovasc Disord
Hashimoto S, Motozawa Y, Mano T.
europepmc   +1 more source

A Case of Success: Guidelines-Based Treatment to Control Atrial Fibrillation-Induced Cardiomyopathy-Atrioventricular Node Ablation and Cardiac Resynchronization Therapy to the Rescue. [PDF]

Reports (MDPI)
Jonaitienė N, Ramantauskaitė G, Laukaitienė J.   +2 more
europepmc   +1 more source